{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:22:36Z","timestamp":1791278556077,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":2410,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1074\/jbc.m113.532143","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T06:05:13Z","timestamp":1389247513000},"page":"5499-5509","update-policy":"https:\/\/doi.org\/10.1074\/jbc.f110.005975","source":"Crossref","is-referenced-by-count":51,"title":["Serglycin Proteoglycan Is Required for Multiple Myeloma Cell Adhesion, in Vivo Growth, and Vascularization"],"prefix":"10.1016","volume":"289","author":[{"given":"Anurag","family":"Purushothaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P.","family":"Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.532143_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/156800912802429337","article-title":"Targeting of adhesion molecules as a therapeutic strategy in multiple myeloma","volume":"12","author":"Neri","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.M113.532143_bib2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/jcb.21213","article-title":"Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment","volume":"101","author":"Mitsiades","year":"2007","journal-title":"J. Cell Biochem"},{"key":"10.1074\/jbc.M113.532143_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10585-007-9125-3","article-title":"Syndecan-1: a dynamic regulator of the myeloma microenvironment","volume":"25","author":"Sanderson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1074\/jbc.M113.532143_bib4","doi-asserted-by":"crossref","first-page":"35116","DOI":"10.1074\/jbc.M601061200","article-title":"Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro","volume":"281","author":"Theocharis","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib5","first-page":"191","article-title":"Proteoglycans in haemopoietic cells","volume":"1032","author":"Kolset","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.532143_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-4165(99)00096-3","article-title":"Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-\u03b1 and IL-1\u03b1","volume":"1428","author":"Kulseth","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.532143_bib7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00018-007-7455-6","article-title":"Serglycin\u2013structure and biology","volume":"65","author":"Kolset","year":"2008","journal-title":"Cell Mol. Life Sci"},{"key":"10.1074\/jbc.M113.532143_bib8","doi-asserted-by":"crossref","first-page":"40897","DOI":"10.1074\/jbc.M405856200","article-title":"Serglycin is essential for maturation of mast cell secretory granule","volume":"279","author":"Abrink","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib9","doi-asserted-by":"crossref","first-page":"33411","DOI":"10.1074\/jbc.M501708200","article-title":"Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage","volume":"280","author":"Grujic","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10719-007-9073-9","article-title":"Serglycin and secretion in human monocytes","volume":"25","author":"Kolset","year":"2008","journal-title":"Glycoconj. J"},{"key":"10.1074\/jbc.M113.532143_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood.V97.2.449","article-title":"Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells","volume":"97","author":"Schick","year":"2001","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.532143_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jcp.1041650113","article-title":"Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288\u201311 and normal human megakaryocytes","volume":"165","author":"Schick","year":"1995","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.M113.532143_bib13","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/0008-5472.CAN-10-3557","article-title":"Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.532143_bib14","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/sj.leu.2404975","article-title":"Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia","volume":"21","author":"Niemann","year":"2007","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M113.532143_bib15","doi-asserted-by":"crossref","first-page":"13558","DOI":"10.1016\/S0021-9258(18)42248-X","article-title":"The human serglycin gene. Nucleotide sequence and methylation pattern in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4 cells","volume":"267","author":"Humphries","year":"1992","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib16","doi-asserted-by":"crossref","first-page":"30377","DOI":"10.1074\/jbc.M111.254789","article-title":"Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype","volume":"286","author":"Purushothaman","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib17","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.1074\/jbc.M806266200","article-title":"Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma","volume":"283","author":"Purushothaman","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib18","doi-asserted-by":"crossref","first-page":"41288","DOI":"10.1074\/jbc.M112.391417","article-title":"Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma","volume":"287","author":"Purushothaman","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib19","doi-asserted-by":"crossref","first-page":"26085","DOI":"10.1074\/jbc.M109.018473","article-title":"Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo","volume":"284","author":"Khotskaya","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib20","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-09-2317","article-title":"Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides","volume":"15","author":"Slomiany","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M113.532143_bib21","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2009-07-234757","article-title":"Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis","volume":"115","author":"Purushothaman","year":"2010","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.532143_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1877-1173(10)93011-1","article-title":"Serglycin proteoglycan deletion in mouse platelets: physiological effects and their implications for platelet contributions to thrombosis, inflammation, atherosclerosis, and metastasis","volume":"93","author":"Schick","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"10.1074\/jbc.M113.532143_bib23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1074\/jbc.M110.151944","article-title":"Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GRO\u03b1\/CXCL1","volume":"286","author":"Meen","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-005-9024-3","article-title":"Endocytosis and degradation of serglycin in liver sinusoidal endothelial cells","volume":"287","author":"Falkowska-Hansen","year":"2006","journal-title":"Mol. Cell Biochem"},{"key":"10.1074\/jbc.M113.532143_bib25","doi-asserted-by":"crossref","first-page":"26714","DOI":"10.1074\/jbc.272.42.26714","article-title":"Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells","volume":"272","author":"Toyama-Sorimachi","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib26","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1074\/jbc.270.13.7437","article-title":"A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation","volume":"270","author":"Toyama-Sorimachi","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib27","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","article-title":"Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities","volume":"15","author":"Toole","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M113.532143_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood.V81.3.767.767","article-title":"Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen","volume":"81","author":"Ridley","year":"1993","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.532143_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.ATV.0000048701.86621.D0","article-title":"Hepatocyte growth factor\/scatter factor can induce angiogenesis independently of vascular endothelial growth factor","volume":"23","author":"Sengupta","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M113.532143_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.0007-1048.2002.03364.x","article-title":"Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma","volume":"116","author":"Iwasaki","year":"2002","journal-title":"Br. J. Haematol"},{"key":"10.1074\/jbc.M113.532143_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V91.3.806","article-title":"Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group","volume":"91","author":"Seidel","year":"1998","journal-title":"Blood"},{"key":"10.1074\/jbc.M113.532143_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.2004.05299.x","article-title":"Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival","volume":"128","author":"Andersen","year":"2005","journal-title":"Br. J. Haematol"},{"key":"10.1074\/jbc.M113.532143_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3324\/haematol.11867","article-title":"Hepatocyte growth factor promotes migration of human myeloma cells","volume":"93","author":"Holt","year":"2008","journal-title":"Haematologica"},{"key":"10.1074\/jbc.M113.532143_bib34","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1073\/pnas.0911929107","article-title":"Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease","volume":"107","author":"Vallet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.532143_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1877-1173(10)93006-8","article-title":"The roles of chondroitin-4-sulfotransferase-1 in development and disease","volume":"93","author":"Kl\u00fcppel","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"10.1074\/jbc.M113.532143_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2141.2009.07633.x","article-title":"Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells","volume":"145","author":"Bret","year":"2009","journal-title":"Br. J. Haematol"},{"key":"10.1074\/jbc.M113.532143_bib37","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1111\/febs.12291","article-title":"In vitro reconstitution of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican","volume":"280","author":"Malla","year":"2013","journal-title":"Febs J"},{"key":"10.1074\/jbc.M113.532143_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2003.08.006","article-title":"RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion","volume":"291","author":"Ab\u00e9cassis","year":"2003","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.M113.532143_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj2820651","article-title":"Proteoglycan synthesis in human erythroleukaemia (HEL) cells","volume":"282","author":"Schick","year":"1992","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M113.532143_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","article-title":"Mast cell proteases","volume":"95","author":"Pejler","year":"2007","journal-title":"Adv. Immunol"},{"key":"10.1074\/jbc.M113.532143_bib41","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1016\/S0021-9258(18)66822-X","article-title":"Complexes of heparin proteoglycans, chondroitin sulfate E proteoglycans, and [3H]diisopropyl fluorophosphate-binding proteins are exocytosed from activated mouse bone marrow-derived mast cells","volume":"261","author":"Serafin","year":"1986","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib42","doi-asserted-by":"crossref","first-page":"26792","DOI":"10.1074\/jbc.M512889200","article-title":"Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-\u03b1 secretion in response to lipopolysaccharide","volume":"281","author":"Zernichow","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/jmbi.2000.4235","article-title":"Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans","volume":"304","author":"Winberg","year":"2000","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.M113.532143_bib44","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1016\/S0021-9258(18)52973-2","article-title":"Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes","volume":"268","author":"Sali","year":"1993","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.532143_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/biof.11","article-title":"Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases","volume":"35","author":"Pejler","year":"2009","journal-title":"Biofactors"},{"key":"10.1074\/jbc.M113.532143_bib46","doi-asserted-by":"crossref","first-page":"e4947","DOI":"10.1371\/journal.pone.0004947","article-title":"Heparanase regulates levels of syndecan-1 in the nucleus","volume":"4","author":"Chen","year":"2009","journal-title":"PLoS One"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820440207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820440207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.532143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T13:54:00Z","timestamp":1639835640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820440207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0021925820440207"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.532143","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}